Home Featured Page 161

Featured

Latest

Poacher Turned Gamekeeper: HHS’ Matt Zorn on Ibogaine, Right to Try and the Psychedelics Executive Order

Podcast: Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks Pricing

Weekly Psychedelic Policy Briefing: October 12, 2026

The Psychedelic Practitioner Issue 7: Preparedness (Systems)

atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial...

Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety...

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform...

PT365 – Dr. Jennifer Montjoy – KAP: Self-Agency Through Intention, Titration,...

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit...

Acid for Anxiety: Fast and Lasting Anxiolytic Effects of LSD

PT364 – Jamie Wheal – Burning Man, Psychedelic Maturity, and Radical...

atai Life Sciences Announces Positive Initial Results for Phase 1 Trial...

EDITOR PICKS

Poacher Turned Gamekeeper: HHS’ Matt Zorn on Ibogaine, Right to Try...

Podcast: Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks...

Weekly Psychedelic Policy Briefing: October 12, 2026

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Poacher Turned Gamekeeper: HHS’ Matt Zorn on Ibogaine, Right to Try and the Psychedelics Executive Order

Podcast: Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks Pricing

Weekly Psychedelic Policy Briefing: October 12, 2026

How to Change Your Behavior

The Psychedelic Practitioner Issue 7: Preparedness (Systems)

atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial...

Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety...

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform...

PT365 – Dr. Jennifer Montjoy – KAP: Self-Agency Through Intention, Titration,...

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit...

Acid for Anxiety: Fast and Lasting Anxiolytic Effects of LSD

PT364 – Jamie Wheal – Burning Man, Psychedelic Maturity, and Radical...

atai Life Sciences Announces Positive Initial Results for Phase 1 Trial...

EDITOR PICKS

Poacher Turned Gamekeeper: HHS’ Matt Zorn on Ibogaine, Right to Try...

Podcast: Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks...

Weekly Psychedelic Policy Briefing: October 12, 2026

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY